Substance / Medication

Losartan

Overview

Active Ingredient
losartan
RxNorm CUI
52175

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Research Evidence

Published studies and systematic reviews

Sort:
Topical losartan ophthalmic drops - a review of corneal wound healing and topical losartan for managing corneal haze and potential future indications.
Abdelghaffar Mariam, Güell José Luis, Moura-Coelho Nuno · Graefes Arch Clin Exp Ophthalmol · 2025
PMID: 39665995Meta-Analysis
Losartan in hospitalized patients with COVID-19 in North America: An individual participant data meta-analysis.
Di Stefano Leon, Ram Malathi, Scharfstein Daniel O et al. · Medicine (Baltimore) · 2023
PMID: 37335665Meta-AnalysisFull text (PMC)
The effects of losartan or angiotensin II receptor antagonists on cartilage: a systematic review.
Yamaura K, Nelson A L, Nishimura H et al. · Osteoarthritis Cartilage · 2023
PMID: 36586717Meta-Analysis
Role of losartan in prevention of aortic dilatation in Marfan syndrome: A systematic review and meta-analysis.
Li Lin, Yamani Naser, Al-Naimat Saed et al. · Eur J Prev Cardiol · 2020
PMID: 31260329Meta-Analysis
The effects of losartan versus beta-blockers on cardiovascular protection in marfan syndrome: A systematic review and meta-analysis.
Kang Yi-No, Chi Sheng-Chu, Wu Mei-Hwan et al. · J Formos Med Assoc · 2020
PMID: 31003918Meta-Analysis
Losartan treatment for hypertensive patients with hyperuricaemia in Chinese population: a meta-analysis.
Fan Yu, Wei Feifei, Lang Yakun et al. · J Hypertens · 2015
PMID: 25915869Meta-Analysis
Enalapril versus losartan for adults with chronic kidney disease: a systematic review and meta-analysis.
He Yuan-Mei, Feng Li, Huo Dong-Mei et al. · Nephrology (Carlton) · 2013
PMID: 23869492Meta-Analysis

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Losartan (substance)
SNOMED CT
373567002
UMLS CUI
C0126174
RxNorm CUI
52175

Clinical Data

This intervention maps to 11 entities in the Healos knowledge graph.

4
Conditions
4
Biomarkers
2
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.